NCT02117687 - A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 14, 2014

Primary Completion Date

January 27, 2015

Study Completion Date

March 17, 2015

Conditions

Dry Eye SyndromesKeratoconjunctivitis Sicca

Interventions

DRUG

carboxymethylcellulose 0.5%/glycerin 0.9%

1-2 drops OPTIVE FUSION™ (carboxymethylcellulose 0.5%/glycerin 0.9%) in each eye as needed at least 2 times and no more than 6 times daily, for 3 months.

DRUG

sodium hyaluronate 0.18%

1-2 drops VISMED® Multi (sodium hyaluronate 0.18%) in each eye as needed at least 2 times and no more than 6 times daily, for 3 months.

Trial Locations (2)

Unknown

Paris

London